HPV

Significantly fewer women screened with HPV testing alone had high-grade pathologies four years later compared to those receiving cytology testing.

IncellDx HPV OncoTect 3Dx system combines the quantification of oncogene mRNA overexpression, proliferation, and aneuploidy in one high-throughput assay, according to the firm.

The firm has launched a multiplex real-time PCR assay that detects HPV 16, HPV 18, and a pool of 12 other high-risk HPV subtypes.

The test runs on the BD Viper LT system and detects 14 high-risk types of human papilloma virus.

The firm also announced the appointment of new board members as it heads toward commercialization of a portable MDx platform.

The test is performed on the company's AmpiProbe platform, and the approval expands Enzo's offering of infectious disease tests in New York.